Hypertension: Update 2017
2016; Lippincott Williams & Wilkins; Volume: 69; Issue: 1 Linguagem: Inglês
10.1161/hypertensionaha.116.08683
ISSN1524-4563
AutoresAnna F. Dominiczak, Denise Kuo,
Tópico(s)Sodium Intake and Health
ResumoHomeHypertensionVol. 69, No. 1Hypertension: Update 2017 Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBHypertension: Update 2017 Anna F. Dominiczak and Denise Kuo Anna F. DominiczakAnna F. Dominiczak From the College of Medical, Veterinary and Life Science, University of Glasgow, United Kingdom. and Denise KuoDenise Kuo From the College of Medical, Veterinary and Life Science, University of Glasgow, United Kingdom. Originally published5 Dec 2016https://doi.org/10.1161/HYPERTENSIONAHA.116.08683Hypertension. 2017;69:3–4Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: January 1, 2016: Previous Version 1 As Hypertension begins its 38th year, the current editorial team, led by Editor-in-Chief Prof. Anna F. Dominiczak and Deputy Editor Prof. Rhian M. Touyz, begins their second 5-year term at the helm of this prestigious Journal. The editors appreciate the time and effort our many readers have spent reviewing manuscripts, submitting the best research to Hypertension, and providing feedback that has improved the Journal. Thank you for the commitment and energy.Although the publishing landscape has changed over the past 5 years, the goals for Hypertension, an American Heart Association (AHA) Journal, remain largely the same. The editorial team continues working on (1) publishing the highest quality original basic, clinical, and population research relating to hypertension, (2) increasing the readership and scientific importance of Hypertension, (3) providing fair and quick reviews for submitted manuscripts followed by rapid publication of all accepted articles, and (4) serving well the international community of hypertension researchers and practitioners while being an important vehicle for achieving the mission of the AHA. On behalf of the entire editorial team, it is with pleasure that we share with you a few key highlights from the past 12 months and also provide a glimpse of what you may expect from the Journal in 2017.Top Papers Published in HypertensionEach June, Hypertension editors select the top 1 or 2 articles in each of 3 categories, basic science, clinical science, population science, published in the Journal throughout the previous calendar year. All six 2015 Top Paper Award articles,1–6 published in 2015 and selected in 2016, were highly accessed by readers and clearly novel and have important clinical implications. The 2015 award winning articles span a wide variety of topics. Those topics include insomnia with physiological hyperarousal, cardiac inflammation and fibrosis, mineralocorticoid receptor antagonism, a meta-analysis of current diuretics, intensive blood pressure lowering in diabetic patients, and low diastolic blood pressure as a potential risk factor for recurrent cardiovascular events.This year for the first time, corresponding authors of each selected Top Paper were not only invited to attend the Council on Hypertension 2016 Scientific Sessions to accept the award in person, but also had the opportunity to discuss the novelty and clinical implications of their work in front of the camera. The short interviews filmed in Orlando during the AHA Council on Hypertension annual conference are available on the AHA Science News YouTube channel (https://www.youtube.com/user/AHAScienceNews).Clinical–Pathological ConferencesConducting a Clinical–Pathological Conference (CPC) at the European Society of Hypertension annual meeting has become a regular event for Hypertension. Again in 2016, 2 cases were presented. Dr David Calvet (Paris) presented an interesting case about ischemic stroke risk in a patient with carotid artery stenosis, and Dr Laurence Amar (Paris) led the international audience through the discussion of a patient with primary aldosteronism but discordant hormonal and computed tomographic findings.This relatively new feature for Hypertension has proven sufficiently popular to warrant expansion to 2 additional conferences in 2016. Two CPC cases were presented for the first time at the AHA Council on Hypertension annual conference held in Orlando, FL, United States, 14 to 17 September. Also in September, the International Society of Hypertension held its biennial conference in Seoul, South Korea. This was an excellent opportunity for Hypertension to conduct yet another CPC session with local presenters and a global audience discussing 2 difficult cases.The videos for all 6 CPC cases filmed in 2016 are available on the Hypertension website; accompanying manuscripts will be published in future issues of the Journal.GuidelinesEarly in 2016, we invited many regional hypertension societies to contribute to a guidelines debate series with the goal of bringing opinions and comments of key leaders involved in regional and international hypertension guidelines to the hypertension community. Researchers representing Hypertension Canada, Latin American Society of Hypertension, International Society of Hypertension, and European Society of Hypertension shared their opinions on the challenges faced by guideline writers and clinicians referring to guidelines in their daily practice.7–10 We look forward to learning how experts across the globe address the difficult questions and concerns discussed in this series and facing clinicians today when the next iteration of guidelines is released over the next few years.Coming in 2017As part of our ongoing effort to improve the author experience with Hypertension, the Journal will feature a streamlined submission process early in 2017. Although there will be a few visual and functional changes to the online submission form, the primary change will be a reduction in the amount of information required to submit an article for peer review.There will be multiple opportunities for hypertension researchers to participate in Journal-sponsored CPC case presentations and discussions in 2017. As each CPC case discussion is not only filmed but also transformed into an article, each audience member significantly contributing to the discussion has an opportunity to be a coauthor of the CPC article. The first opportunity to participate in a CPC will be in Milan at the 27th European Congress on Hypertension and Cardiovascular Protection in June, and later in the year, there will be another opportunity in San Francisco at the AHA Council on Hypertension 2017 Scientific Sessions.In summary, your Journal is thriving, and the editorial team is poised to deliver the best possible science in the next 5 years. We look forward to publishing the all-important hypertension guidelines, and we are also looking forward to receiving your best articles in basic, clinical, and population research. Among these, we would be particularly interested to publish on recent advances in precision medicine because this theme grows in significance in the United States and worldwide.DisclosuresNone.FootnotesThe opinions expressed in this article are not necessarily those of the American Heart Association.Correspondence to Anna F. Dominiczak, Hypertension, AHA, 7272 Greenville Avenue, Dallas, TX 75231-4596. E-mail [email protected]References1. Roush GC, Ernst ME, Kostis JB, Tandon S, Sica DA. Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: antihypertensive and metabolic effects.Hypertension. 2015; 65:1041–1046. doi: 10.1161/HYPERTENSIONAHA.114.05021.LinkGoogle Scholar2. Li Y, Vgontzas AN, Fernandez-Mendoza J, Bixler EO, Sun Y, Zhou J, Ren R, Li T, Tang X. Insomnia with physiological hyperarousal is associated with hypertension.Hypertension. 2015; 65:644–650. doi: 10.1161/HYPERTENSIONAHA.114.04604.LinkGoogle Scholar3. Wang X, Wang HX, Li YL, Zhang CC, Zhou CY, Wang L, Xia YL, Du J, Li HH. MicroRNA Let-7i negatively regulates cardiac inflammation and fibrosis.Hypertension. 2015; 66:776–785. doi: 10.1161/HYPERTENSIONAHA.115.05548.LinkGoogle Scholar4. Bender SB, DeMarco VG, Padilla J, Jenkins NT, Habibi J, Garro M, Pulakat L, Aroor AR, Jaffe IZ, Sowers JR. Mineralocorticoid receptor antagonism treats obesity-associated cardiac diastolic dysfunction.Hypertension. 2015; 65:1082–1088. doi: 10.1161/HYPERTENSIONAHA.114.04912.LinkGoogle Scholar5. Franklin SS, Gokhale SS, Chow VH, Larson MG, Levy D, Vasan RS, Mitchell GF, Wong ND. Does low diastolic blood pressure contribute to the risk of recurrent hypertensive cardiovascular disease events? The Framingham Heart Study.Hypertension. 2015; 65:299–305. doi: 10.1161/HYPERTENSIONAHA.114.04581.LinkGoogle Scholar6. Soliman EZ, Byington RP, Bigger JT, Evans G, Okin PM, Goff DC, Chen H. Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with diabetes mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial.Hypertension. 2015; 66:1123–1129. doi: 10.1161/HYPERTENSIONAHA.115.06236.LinkGoogle Scholar7. Weber MA, Poulter NR, Schutte AE, Burrell LM, Horiuchi M, Prabhakaran D, Ramirez AJ, Wang JG, Schiffrin EL, Touyz RM. Is it time to reappraise blood pressure thresholds and targets? A statement from the International Society of Hypertension-a global perspective.Hypertension. 2016; 68:266–268. doi: 10.1161/HYPERTENSIONAHA.116.07818.LinkGoogle Scholar8. Rosei EA. Target blood pressure for treatment: should current recommendations be changed?Hypertension. 2016; 68:263–265. doi: 10.1161/HYPERTENSIONAHA.116.07469.LinkGoogle Scholar9. López-Jaramillo P, Coca A, Sánchez R, Zanchetti A; Latin American Society of Hypertension. Hypertension guidelines: is it time to reappraise blood pressure thresholds and targets? Position statement of the Latin American Society of Hypertension.Hypertension. 2016; 68:257–262. doi: 10.1161/HYPERTENSIONAHA.116.07738.LinkGoogle Scholar10. Padwal R, Rabi DM, Schiffrin EL. Recommendations for intensive blood pressure lowering in high-risk patients, the Canadian Viewpoint.Hyper tension. 2016; 68:3–5. doi: 10.1161/HYPERTENSIONAHA.116.07573.LinkGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Winter W and Harris N (2021) Laboratory evaluation of endocrine hypertension Handbook of Diagnostic Endocrinology, 10.1016/B978-0-12-818277-2.00011-X, (391-447), . Ding C, Luo L and Huang X (2021) Hypertension Encyclopedia of Gerontology and Population Aging, 10.1007/978-3-030-22009-9_1046, (2527-2537), . Ding C, Luo L and Huang X (2020) Hypertension Encyclopedia of Gerontology and Population Aging, 10.1007/978-3-319-69892-2_1046-1, (1-11), . Zhang J, Hu W and Li C (2019) A Review of the Epidemiological Evidence for Adducin Family Gene Polymorphisms and Hypertension, Cardiology Research and Practice, 10.1155/2019/7135604, 2019, (1-6), Online publication date: 2-Jun-2019. Rivera S, Martin J and Landry J (2019) Acute and Chronic Hypertension, Critical Care Nursing Clinics of North America, 10.1016/j.cnc.2018.11.008, 31:1, (97-108), Online publication date: 1-Mar-2019. Carey R, Muntner P, Bosworth H and Whelton P (2018) Reprint of: Prevention and Control of Hypertension, Journal of the American College of Cardiology, 10.1016/j.jacc.2018.10.022, 72:23, (2996-3011), Online publication date: 1-Dec-2018. Whelton P, Carey R, Aronow W, Casey D, Collins K, Dennison Himmelfarb C, DePalma S, Gidding S, Jamerson K, Jones D, MacLaughlin E, Muntner P, Ovbiagele B, Smith S, Spencer C, Stafford R, Taler S, Thomas R, Williams K, Williamson J and Wright J (2018) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, Circulation, 138:17, (e484-e594), Online publication date: 23-Oct-2018. Carey R, Muntner P, Bosworth H and Whelton P (2018) Prevention and Control of Hypertension, Journal of the American College of Cardiology, 10.1016/j.jacc.2018.07.008, 72:11, (1278-1293), Online publication date: 1-Sep-2018. Tzani A, Doulamis I, Konstantopoulos P, Pasiou E, Daskalopoulou A, Iliopoulos D, Georgiadis I, Kavantzas N, Kourkoulis S and Perrea D (2018) Chios mastic gum decreases renin levels and ameliorates vascular remodeling in renovascular hypertensive rats, Biomedicine & Pharmacotherapy, 10.1016/j.biopha.2018.06.067, 105, (899-906), Online publication date: 1-Sep-2018. Whelton P, Carey R, Aronow W, Casey D, Collins K, Dennison Himmelfarb C, DePalma S, Gidding S, Jamerson K, Jones D, MacLaughlin E, Muntner P, Ovbiagele B, Smith S, Spencer C, Stafford R, Taler S, Thomas R, Williams K, Williamson J and Wright J (2017) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, Hypertension, 71:6, (e13-e115), Online publication date: 1-Jun-2018.Sun D, Li X, Heianza Y, Nisa H, Shang X, Rabito F, Kelly T, Harville E, Li S, He J, Bazzano L, Chen W and Qi L (2018) History of Asthma From Childhood and Arterial Stiffness in Asymptomatic Young Adults, Hypertension, 71:5, (928-936), Online publication date: 1-May-2018. Whelton P, Carey R, Aronow W, Casey D, Collins K, Dennison Himmelfarb C, DePalma S, Gidding S, Jamerson K, Jones D, MacLaughlin E, Muntner P, Ovbiagele B, Smith S, Spencer C, Stafford R, Taler S, Thomas R, Williams K, Williamson J and Wright J (2018) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults, Journal of the American College of Cardiology, 10.1016/j.jacc.2017.11.006, 71:19, (e127-e248), Online publication date: 1-May-2018. January 2017Vol 69, Issue 1 Advertisement Article InformationMetrics © 2016 American Heart Association, Inc.https://doi.org/10.1161/HYPERTENSIONAHA.116.08683PMID: 27920130 Originally publishedDecember 5, 2016 PDF download Advertisement SubjectsBasic Science ResearchClinical StudiesEpidemiologyHigh Blood PressureHypertension
Referência(s)